EcoDrugPlus


Synonyms	2-Hydroxyacetic Acid Glycolate Glycolic acid Hydroxyacetic acid NSC-166
Status
Molecule Category	UNKNOWN
UNII	0WT12SX38S
EPA CompTox	DTXSID0025363

Synonyms

2-Hydroxyacetic Acid

Glycolate

Glycolic acid

Hydroxyacetic acid

NSC-166

Status

Molecule Category

UNKNOWN

UNII

0WT12SX38S

EPA CompTox

DTXSID0025363


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	AEMRFAOFKBGASW-UHFFFAOYSA-N
Smiles	O=C(O)CO
InChI	InChI=1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5)

InChI Key

AEMRFAOFKBGASW-UHFFFAOYSA-N

Smiles

O=C(O)CO

InChI

InChI=1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5)

Property Name	Value
Molecular Formula	C2H4O3
Molecular Weight	76.05
AlogP	-0.94
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	2.0
Number of Rotational Bond	1.0
Polar Surface Area	57.53
Molecular species	ACID
Aromatic Rings	0.0
Heavy Atoms	5.0

Property Name

Value

Molecular Formula

C2H4O3

Molecular Weight

76.05

AlogP

-0.94

Hydrogen Bond Acceptor

2.0

Hydrogen Bond Donor

2.0

Number of Rotational Bond

1.0

Polar Surface Area

57.53

Molecular species

ACID

Aromatic Rings

0.0

Heavy Atoms

5.0

Resources	Reference
ChEBI	17497
ChEMBL	CHEMBL252557
DrugBank	DB03085
DrugCentral	4645
FDA SRS	0WT12SX38S
Human Metabolome Database	HMDB0000115
KEGG	C03547
PDB	GOA
PubChem	757
SureChEMBL	SCHEMBL1222
ZINC	ZINC000004658557

Resources

Reference

ChEBI

ChEMBL

DrugBank

DrugCentral

FDA SRS

Human Metabolome Database

KEGG

PDB

PubChem

SureChEMBL

ZINC


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

GLYCOLIC ACID

Structure

Physicochemical Descriptors

Cross References